Intended for healthcare professionals


Sixty seconds on . . . prostate cancer screening

BMJ 2019; 365 doi: (Published 10 June 2019) Cite this as: BMJ 2019;365:l4157
  1. Elisabeth Mahase
  1. The BMJ

Uh oh, there’s that “S” word again . . .

Screening is often a controversial topic within medicine, and a new £5m (€5.6m; $6.3m) trial offering magnetic resonance imaging (MRI) scans to test asymptomatic men for prostate cancer will have raised eyebrows this week after being hyped in the national press. The trial, starting in August, is funded by the Medical Research Council and Cancer Research UK. It will invite 1000 men aged between 55 and 75 years to …

View Full Text

Log in

Log in through your institution


* For online subscription